Similar articles

• Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.

  Morris RE, Wang J, Blum JR, Flavin T, Murphy MP, Almquist SJ, Chu N, Tam YL, Kaloostian M, Allison AC, et al. Morris RE, et al. Transplant Proc. 1991 Apr;23(2 Suppl 2):19-25. Transplant Proc. 1991. PMID: 2063417 No abstract available.
• Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.

  Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC. Morris RE, et al. Transplant Proc. 1990 Aug;22(4):1659-62. Transplant Proc. 1990. PMID: 2389428 No abstract available.
• A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.

  Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE. Nakakura EK, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):809-12. Transplant Proc. 1993. PMID: 8438493 No abstract available.
• Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.

  Taylor DO, Ensley RD, Olsen SL, Dunn D, Renlund DG. Taylor DO, et al. J Heart Lung Transplant. 1994 Jul-Aug;13(4):571-82. J Heart Lung Transplant. 1994. PMID: 7947873 Review.
• Emergency department presentation of heart transplant recipients with acute heart failure.

  Chacko P, Philip S. Chacko P, et al. Heart Fail Clin. 2009 Jan;5(1):129-43, viii. doi: 10.1016/j.hfc.2008.08.011. Heart Fail Clin. 2009. PMID: 19026393 Review.